160 related articles for article (PubMed ID: 36418572)
1. Proactive therapeutic drug monitoring of vincristine in pediatric and adult cancer patients: current supporting evidence and future efforts.
Wu CY; Li GT; Chu CC; Guo HL; Fang WR; Li T; Wang YR; Xu J; Hu YH; Zhou L; Chen F
Arch Toxicol; 2023 Feb; 97(2):377-392. PubMed ID: 36418572
[TBL] [Abstract][Full Text] [Related]
2. Model-Informed Precision Dosing to Reduce Vincristine-Induced Peripheral Neuropathy in Pediatric Patients: A Pharmacokinetic and Pharmacodynamic Modeling and Simulation Analysis.
Centanni M; van de Velde ME; Uittenboogaard A; Kaspers GJL; Karlsson MO; Friberg LE
Clin Pharmacokinet; 2024 Feb; 63(2):197-209. PubMed ID: 38141094
[TBL] [Abstract][Full Text] [Related]
3. Vincristine-Induced Peripheral Neuropathy in Childhood Acute Lymphoblastic Leukemia: Genetic Variation as a Potential Risk Factor.
Yang QY; Hu YH; Guo HL; Xia Y; Zhang Y; Fang WR; Li YM; Xu J; Chen F; Wang YR; Wang TF
Front Pharmacol; 2021; 12():771487. PubMed ID: 34955843
[TBL] [Abstract][Full Text] [Related]
4. Genetic polymorphisms and vincristine-induced peripheral neuropathy in patients treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone therapy.
Sawaki A; Miyazaki K; Yamaguchi M; Takeuchi T; Kobayashi K; Imai H; Tawara I; Ono R; Nosaka T; Katayama N
Int J Hematol; 2020 May; 111(5):686-691. PubMed ID: 31993939
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous quantification and pharmacokinetics of vincristine and its major metabolite M1 in Chinese pediatric ALL patients by LC-MS/MS.
Yuan Y; Chen C; You G; Yao R; Zhu X; Wu X; Wu J; Zhao W; Li Z; Zhang S
J Pharm Biomed Anal; 2023 Sep; 234():115578. PubMed ID: 37459833
[TBL] [Abstract][Full Text] [Related]
6. CYP3A5 genotype and its impact on vincristine pharmacokinetics and development of neuropathy in Kenyan children with cancer.
Skiles JL; Chiang C; Li CH; Martin S; Smith EL; Olbara G; Jones DR; Vik TA; Mostert S; Abbink F; Kaspers GJ; Li L; Njuguna F; Sajdyk TJ; Renbarger JL
Pediatr Blood Cancer; 2018 Mar; 65(3):. PubMed ID: 29115708
[TBL] [Abstract][Full Text] [Related]
7. Vincristine-induced peripheral neuropathy in children with cancer: A systematic review.
van de Velde ME; Kaspers GL; Abbink FCH; Wilhelm AJ; Ket JCF; van den Berg MH
Crit Rev Oncol Hematol; 2017 Jun; 114():114-130. PubMed ID: 28477739
[TBL] [Abstract][Full Text] [Related]
8. Genetic Polymorphisms Associated with Vincristine Pharmacokinetics and Vincristine-Induced Peripheral Neuropathy in Pediatric Oncology Patients.
van de Velde ME; Uittenboogaard A; Yang W; Bonten E; Cheng C; Pei D; van den Berg MH; van der Sluis IM; van den Bos C; Abbink FCH; van den Heuvel-Eibrink MM; Segers H; Chantrain C; van der Werff Ten Bosch J; Willems L; Evans WE; Kaspers GJL
Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884569
[TBL] [Abstract][Full Text] [Related]
9. Vincristine-induced peripheral neuropathy: A mini-review.
Li GZ; Hu YH; Li DY; Zhang Y; Guo HL; Li YM; Chen F; Xu J
Neurotoxicology; 2020 Dec; 81():161-171. PubMed ID: 33053366
[TBL] [Abstract][Full Text] [Related]
10. The effect of increased lipoproteins levels on the disposition of vincristine in rat.
Khalil HA; Belal TS; El-Yazbi AF; Hamdy DA
Lipids Health Dis; 2016 Sep; 15(1):152. PubMed ID: 27613245
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and pharmacodynamics of vincristine sulfate liposome injection (VSLI) in adults with acute lymphoblastic leukemia.
Silverman JA; Reynolds L; Deitcher SR
J Clin Pharmacol; 2013 Nov; 53(11):1139-45. PubMed ID: 23907766
[TBL] [Abstract][Full Text] [Related]
12. Effect of pyridoxine plus pyridostigmine treatment on vincristine-induced peripheral neuropathy in pediatric patients with acute lymphoblastic leukemia: a single-center experience.
Aydin Köker S; Gözmen S; Demirağ B; Ünalp A; Karapinar TH; Oymak Y; Gürbüz G; Öner Eİ; Vergin RC
Neurol Sci; 2021 Sep; 42(9):3681-3686. PubMed ID: 33439396
[TBL] [Abstract][Full Text] [Related]
13. Vincristine disposition in children with acute lymphoblastic leukemia.
de Graaf SS; Bloemhof H; Vendrig DE; Uges DR
Med Pediatr Oncol; 1995 Apr; 24(4):235-40. PubMed ID: 7700168
[TBL] [Abstract][Full Text] [Related]
14. Patterns and severity of vincristine-induced peripheral neuropathy in children with acute lymphoblastic leukemia.
Lavoie Smith EM; Li L; Chiang C; Thomas K; Hutchinson RJ; Wells EM; Ho RH; Skiles J; Chakraborty A; Bridges CM; Renbarger J
J Peripher Nerv Syst; 2015 Mar; 20(1):37-46. PubMed ID: 25977177
[TBL] [Abstract][Full Text] [Related]
15. Risk Factors for Early-Onset Peripheral Neuropathy Caused by Vincristine in Patients With a First Administration of R-CHOP or R-CHOP-Like Chemotherapy.
Okada N; Hanafusa T; Sakurada T; Teraoka K; Kujime T; Abe M; Shinohara Y; Kawazoe K; Minakuchi K
J Clin Med Res; 2014 Aug; 6(4):252-60. PubMed ID: 24883150
[TBL] [Abstract][Full Text] [Related]
16. Fluoroquinolone prophylaxis does not increase risk of neuropathy in children with acute lymphoblastic leukemia.
Karol SE; Sun Y; Tang L; Pui CH; Ferrolino J; Allison KJ; Cross SJ; Evans WE; Crews KR; Jeha S; Wolf J
Cancer Med; 2020 Sep; 9(18):6550-6555. PubMed ID: 32710497
[TBL] [Abstract][Full Text] [Related]
17. Prospective assessment of vincristine-induced peripheral neuropathy in paediatric acute lymphoblastic leukemia.
Li T; Kandula T; Cohn RJ; Kiernan MC; Park SB; Farrar MA
Clin Neurophysiol; 2023 Oct; 154():157-168. PubMed ID: 37633123
[TBL] [Abstract][Full Text] [Related]
18. Vincristine-induced peripheral neuropathy in survivors of childhood acute lymphoblastic leukaemia.
Tay CG; Lee VWM; Ong LC; Goh KJ; Ariffin H; Fong CY
Pediatr Blood Cancer; 2017 Aug; 64(8):. PubMed ID: 28139029
[TBL] [Abstract][Full Text] [Related]
19. Identification of small molecules that mitigate vincristine-induced neurotoxicity while sensitizing leukemia cells to vincristine.
Diouf B; Wing C; Panetta JC; Eddins D; Lin W; Yang W; Fan Y; Pei D; Cheng C; Delaney SM; Zhang W; Bonten EJ; Crews KR; Paugh SW; Li L; Freeman BB; Autry RJ; Beard JA; Ferguson DC; Janke LJ; Ness KK; Chen T; Zakharenko SS; Jeha S; Pui CH; Relling MV; Eileen Dolan M; Evans WE
Clin Transl Sci; 2021 Jul; 14(4):1490-1504. PubMed ID: 33742760
[TBL] [Abstract][Full Text] [Related]
20. Vincristine-Loaded and sgc8-Modified Liposome as a Potential Targeted Drug Delivery System for Treating Acute Lymphoblastic Leukemia.
Duan S; Yu Y; Lai C; Wang D; Wang Y; Xue D; Hu Z; Lu X
J Biomed Nanotechnol; 2018 May; 14(5):910-921. PubMed ID: 29883561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
